With over 50 years of combined clinical experience in pharmacology, biotechnology, cell biology and biopharmaceutical approaches LAB RMS is leading the way as one of the fastest growing biopharmaceutical companies.
Peptides are the focus of the LAB RMS line of therapies. Peptide-based therapeutics now represent one of the fastest growing classes of new drug therapy in the pharmaceutical industry. While they currently account for only 2% of drugs on the market, they comprise roughly 50% of drugs in the pipelines of major drug manufacturers. Additionally, the market for peptide drugs is growing at a compound annual rate of 7.5% and has been estimated to be in excess of $13 billion this year.
Peptides are short chains of 20 or fewer amino acids-shorter than proteins. Natural cellular and tissue regeneration involve peptide chains; they can either induce or inhibit biological effects, acting as agonists or antagonists in physiological systems. When used therapeutically, peptides are highly specific in their activity and effective at low doses with no toxicity or minimal side effects as they are know to human physiology and no foreign.
From experiment to medical substances
The administration of peptide bio-regulators enables effective prevention of premature ageing and therapy of age-related diseases. Peptides control gene expression and protein synthesis, thus preventing age-related accumulation of quantitative structural and functional alterations that cause rapid aging and disease. Peptide bio-regulation reduces organism. Peptides allow us to control aging at the level of the genetic code.
With over 50 years of combined clinical experience in pharmacology, biotechnology, cell biology and biopharmaceutical approaches LAB RMS is leading the way as one of the fastest growing biopharmaceutical companies.
Peptides are the focus of the LAB RMS line of therapies. Peptide-based therapeutics now represent one of the fastest growing classes of new drug therapy in the pharmaceutical industry. While they currently account for only 2% of drugs on the market, they comprise roughly 50% of drugs in the pipelines of major drug manufacturers. Additionally, the market for peptide drugs is growing at a compound annual rate of 7.5% and has been estimated to be in excess of $13 billion this year.
Peptides are short chains of 20 or fewer amino acids-shorter than proteins. Natural cellular and tissue regeneration involve peptide chains; they can either induce or inhibit biological effects, acting as agonists or antagonists in physiological systems. When used therapeutically, peptides are highly specific in their activity and effective at low doses with no toxicity or minimal side effects as they are know to human physiology and no foreign.
From experiment to medical substances
The administration of peptide bio-regulators enables effective prevention of premature ageing and therapy of age-related diseases. Peptides control gene expression and protein synthesis, thus preventing age-related accumulation of quantitative structural and functional alterations that cause rapid aging and disease. Peptide bio-regulation reduces organism. Peptides allow us to control aging at the level of the genetic code.
การแปล กรุณารอสักครู่..